 | • レポートコード：MRCLP3DB8752 • 出版社/出版日：LP Information / 2023年12月 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（納期：2-3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥549,000 (USD3,660) | ▷ お問い合わせ |
| Corporate User | ￥1,098,000 (USD7,320) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| LPインフォメーション社の最新調査レポート「医療用ニコチン経皮パッチの世界市場」は、過去の販売実績から2022年の世界の医療用ニコチン経皮パッチの総販売量を検討し、2023年から2029年の予測される医療用ニコチン経皮パッチの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の医療用ニコチン経皮パッチの市場規模を掲載し、XXX百万米ドル規模の世界の医療用ニコチン経皮パッチ市場の詳細な分析を提供します。本インサイトレポートは、世界の医療用ニコチン経皮パッチ業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。 また、本資料では、加速する世界の医療用ニコチン経皮パッチ市場における各社の独自のポジションをより深く理解するために、医療用ニコチン経皮パッチ製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。 世界の医療用ニコチン経皮パッチ市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。医療用ニコチン経皮パッチの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。医療用ニコチン経皮パッチの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。医療用ニコチン経皮パッチの欧州市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。 医療用ニコチン経皮パッチの世界主要メーカーとしては、Habitrol、 Nicotrol、 Nicoderm、 Aroamas Cot、 Hisamitsu Pharmaceutica、 Novartis、 Johnson & Johnson、 Teikoku Pharma、 Mylan、 Actavis、 Mundipharma、 Henan Lingrui pharmaceutical、 Changzhou Siyao、 Rfl Pharmaceutical、 Luye Pharma Group Ltd.、 Purdue Pharma L.P、 Teva Pharmaceutical Industriesなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。 本調査資料では、製品タイプ、用途、主要メーカー、主要地域、国別の医療用ニコチン経皮パッチ市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。 【市場細分化】 本調査では医療用ニコチン経皮パッチ市場をセグメンテーションし、種類別 (21mg、14mg、7mg)、用途別 (禁煙センター、病院、家庭、その他)、および地域別 (アジア太平洋、南北アメリカ、欧州、および中東・アフリカ) の市場規模を予測しています。 ・種類別区分：21mg、14mg、7mg ・用途別区分：禁煙センター、病院、家庭、その他 ・地域別区分 南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル） アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア） 欧州（ドイツ、フランス、イギリス、イタリア、ロシア） 中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国） 【本レポートで扱う主な質問】 ・世界の医療用ニコチン経皮パッチ市場の10年間の市場状況・展望は？ ・世界および地域別に見た医療用ニコチン経皮パッチ市場成長の要因は何か？ ・医療用ニコチン経皮パッチの市場機会はエンドマーケットの規模によってどのように変化するのか？ ・医療用ニコチン経皮パッチのタイプ別、用途別の内訳は？ ・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？ ********* 目次 ********* レポートの範囲 ・市場の紹介 ・分析対象期間 ・調査の目的 ・調査手法 ・調査プロセスおよびデータソース ・経済指標 ・通貨 エグゼクティブサマリー ・世界市場の概要：医療用ニコチン経皮パッチの年間販売量2018-2029、地域別現状・将来分析 ・医療用ニコチン経皮パッチの種類別セグメント：21mg、14mg、7mg ・医療用ニコチン経皮パッチの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格 ・医療用ニコチン経皮パッチの用途別セグメント：禁煙センター、病院、家庭、その他 ・医療用ニコチン経皮パッチの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格 企業別世界の医療用ニコチン経皮パッチ市場 ・企業別のグローバル医療用ニコチン経皮パッチ市場データ：2018-2023年の年間販売量、市場シェア ・企業別の医療用ニコチン経皮パッチの年間売上：2018-2023年の売上、市場シェア ・企業別の医療用ニコチン経皮パッチ販売価格 ・主要企業の医療用ニコチン経皮パッチ生産地域、販売地域、製品タイプ ・市場集中度分析 ・新製品および潜在的な参加者 ・合併と買収、拡大 医療用ニコチン経皮パッチの地域別レビュー ・地域別の医療用ニコチン経皮パッチ市場規模2018-2023：年間販売量、売上 ・主要国別の医療用ニコチン経皮パッチ市場規模2018-2023：年間販売量、売上 ・南北アメリカの医療用ニコチン経皮パッチ販売の成長 ・アジア太平洋の医療用ニコチン経皮パッチ販売の成長 ・欧州の医療用ニコチン経皮パッチ販売の成長 ・中東・アフリカの医療用ニコチン経皮パッチ販売の成長 南北アメリカ市場 ・南北アメリカの国別の医療用ニコチン経皮パッチ販売量、売上（2018-2023） ・南北アメリカの医療用ニコチン経皮パッチの種類別販売量 ・南北アメリカの医療用ニコチン経皮パッチの用途別販売量 ・アメリカ市場 ・カナダ市場 ・メキシコ市場 ・ブラジル市場 アジア太平洋市場 ・アジア太平洋の国別の医療用ニコチン経皮パッチ販売量、売上（2018-2023） ・アジア太平洋の医療用ニコチン経皮パッチの種類別販売量 ・アジア太平洋の医療用ニコチン経皮パッチの用途別販売量 ・中国市場 ・日本市場 ・韓国市場 ・東南アジア市場 ・インド市場 ・オーストラリア市場 ・台湾市場 欧州市場 ・欧州の国別の医療用ニコチン経皮パッチ販売量、売上（2018-2023） ・欧州の医療用ニコチン経皮パッチの種類別販売量 ・欧州の医療用ニコチン経皮パッチの用途別販売量 ・ドイツ市場 ・フランス市場 ・イギリス市場 ・イタリア市場 ・ロシア市場 中東・アフリカ市場 ・中東・アフリカの国別の医療用ニコチン経皮パッチ販売量、売上（2018-2023） ・中東・アフリカの医療用ニコチン経皮パッチの種類別販売量 ・中東・アフリカの医療用ニコチン経皮パッチの用途別販売量 ・エジプト市場 ・南アフリカ市場 ・イスラエル市場 ・トルコ市場 ・GCC諸国市場 市場の成長要因、課題、動向 ・市場の成長要因および成長機会分析 ・市場の課題およびリスク ・市場動向 製造コスト構造分析 ・原材料とサプライヤー ・医療用ニコチン経皮パッチの製造コスト構造分析 ・医療用ニコチン経皮パッチの製造プロセス分析 ・医療用ニコチン経皮パッチの産業チェーン構造 マーケティング、販売業者および顧客 ・販売チャンネル：直接販売チャンネル、間接販売チャンネル ・医療用ニコチン経皮パッチの主要なグローバル販売業者 ・医療用ニコチン経皮パッチの主要なグローバル顧客 地域別の医療用ニコチン経皮パッチ市場予測レビュー ・地域別の医療用ニコチン経皮パッチ市場規模予測（2024-2029） ・南北アメリカの国別予測 ・アジア太平洋の国別予測 ・欧州の国別予測 ・医療用ニコチン経皮パッチの種類別市場規模予測 ・医療用ニコチン経皮パッチの用途別市場規模予測 主要企業分析 Habitrol、 Nicotrol、 Nicoderm、 Aroamas Cot、 Hisamitsu Pharmaceutica、 Novartis、 Johnson & Johnson、 Teikoku Pharma、 Mylan、 Actavis、 Mundipharma、 Henan Lingrui pharmaceutical、 Changzhou Siyao、 Rfl Pharmaceutical、 Luye Pharma Group Ltd.、 Purdue Pharma L.P、 Teva Pharmaceutical Industries ・企業情報 ・医療用ニコチン経皮パッチ製品 ・医療用ニコチン経皮パッチ販売量、売上、価格、粗利益（2018-2023） ・主要ビジネス概要 ・最新動向 調査結果および結論 |
The global Medical Nicotine Transdermal Skin Patch market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Medical Nicotine Transdermal Skin Patch is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Medical Nicotine Transdermal Skin Patch is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Medical Nicotine Transdermal Skin Patch is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Medical Nicotine Transdermal Skin Patch players cover Habitrol, Nicotrol, Nicoderm, Aroamas Cot, Hisamitsu Pharmaceutica, Novartis, Johnson & Johnson, Teikoku Pharma and Mylan, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Medical Nicotine Transdermal Skin Patch Industry Forecast” looks at past sales and reviews total world Medical Nicotine Transdermal Skin Patch sales in 2022, providing a comprehensive analysis by region and market sector of projected Medical Nicotine Transdermal Skin Patch sales for 2023 through 2029. With Medical Nicotine Transdermal Skin Patch sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Nicotine Transdermal Skin Patch industry.
This Insight Report provides a comprehensive analysis of the global Medical Nicotine Transdermal Skin Patch landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Nicotine Transdermal Skin Patch portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medical Nicotine Transdermal Skin Patch market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Nicotine Transdermal Skin Patch and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Nicotine Transdermal Skin Patch.
This report presents a comprehensive overview, market shares, and growth opportunities of Medical Nicotine Transdermal Skin Patch market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
21 mg
14 mg
7 mg
Segmentation by application
Smoking Cessation Centres
Hospitals
Home
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Habitrol
Nicotrol
Nicoderm
Aroamas Cot
Hisamitsu Pharmaceutica
Novartis
Johnson & Johnson
Teikoku Pharma
Mylan
Actavis
Mundipharma
Henan Lingrui pharmaceutical
Changzhou Siyao
Rfl Pharmaceutical
Luye Pharma Group Ltd.
Purdue Pharma L.P
Teva Pharmaceutical Industries
Key Questions Addressed in this Report
What is the 10-year outlook for the global Medical Nicotine Transdermal Skin Patch market?
What factors are driving Medical Nicotine Transdermal Skin Patch market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Medical Nicotine Transdermal Skin Patch market opportunities vary by end market size?
How does Medical Nicotine Transdermal Skin Patch break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Medical Nicotine Transdermal Skin Patch Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Medical Nicotine Transdermal Skin Patch by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Medical Nicotine Transdermal Skin Patch by Country/Region, 2018, 2022 & 2029
2.2 Medical Nicotine Transdermal Skin Patch Segment by Type
2.2.1 21 mg
2.2.2 14 mg
2.2.3 7 mg
2.3 Medical Nicotine Transdermal Skin Patch Sales by Type
2.3.1 Global Medical Nicotine Transdermal Skin Patch Sales Market Share by Type (2018-2023)
2.3.2 Global Medical Nicotine Transdermal Skin Patch Revenue and Market Share by Type (2018-2023)
2.3.3 Global Medical Nicotine Transdermal Skin Patch Sale Price by Type (2018-2023)
2.4 Medical Nicotine Transdermal Skin Patch Segment by Application
2.4.1 Smoking Cessation Centres
2.4.2 Hospitals
2.4.3 Home
2.4.4 Others
2.5 Medical Nicotine Transdermal Skin Patch Sales by Application
2.5.1 Global Medical Nicotine Transdermal Skin Patch Sale Market Share by Application (2018-2023)
2.5.2 Global Medical Nicotine Transdermal Skin Patch Revenue and Market Share by Application (2018-2023)
2.5.3 Global Medical Nicotine Transdermal Skin Patch Sale Price by Application (2018-2023)
3 Global Medical Nicotine Transdermal Skin Patch by Company
3.1 Global Medical Nicotine Transdermal Skin Patch Breakdown Data by Company
3.1.1 Global Medical Nicotine Transdermal Skin Patch Annual Sales by Company (2018-2023)
3.1.2 Global Medical Nicotine Transdermal Skin Patch Sales Market Share by Company (2018-2023)
3.2 Global Medical Nicotine Transdermal Skin Patch Annual Revenue by Company (2018-2023)
3.2.1 Global Medical Nicotine Transdermal Skin Patch Revenue by Company (2018-2023)
3.2.2 Global Medical Nicotine Transdermal Skin Patch Revenue Market Share by Company (2018-2023)
3.3 Global Medical Nicotine Transdermal Skin Patch Sale Price by Company
3.4 Key Manufacturers Medical Nicotine Transdermal Skin Patch Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Medical Nicotine Transdermal Skin Patch Product Location Distribution
3.4.2 Players Medical Nicotine Transdermal Skin Patch Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Medical Nicotine Transdermal Skin Patch by Geographic Region
4.1 World Historic Medical Nicotine Transdermal Skin Patch Market Size by Geographic Region (2018-2023)
4.1.1 Global Medical Nicotine Transdermal Skin Patch Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Medical Nicotine Transdermal Skin Patch Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Medical Nicotine Transdermal Skin Patch Market Size by Country/Region (2018-2023)
4.2.1 Global Medical Nicotine Transdermal Skin Patch Annual Sales by Country/Region (2018-2023)
4.2.2 Global Medical Nicotine Transdermal Skin Patch Annual Revenue by Country/Region (2018-2023)
4.3 Americas Medical Nicotine Transdermal Skin Patch Sales Growth
4.4 APAC Medical Nicotine Transdermal Skin Patch Sales Growth
4.5 Europe Medical Nicotine Transdermal Skin Patch Sales Growth
4.6 Middle East & Africa Medical Nicotine Transdermal Skin Patch Sales Growth
5 Americas
5.1 Americas Medical Nicotine Transdermal Skin Patch Sales by Country
5.1.1 Americas Medical Nicotine Transdermal Skin Patch Sales by Country (2018-2023)
5.1.2 Americas Medical Nicotine Transdermal Skin Patch Revenue by Country (2018-2023)
5.2 Americas Medical Nicotine Transdermal Skin Patch Sales by Type
5.3 Americas Medical Nicotine Transdermal Skin Patch Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Medical Nicotine Transdermal Skin Patch Sales by Region
6.1.1 APAC Medical Nicotine Transdermal Skin Patch Sales by Region (2018-2023)
6.1.2 APAC Medical Nicotine Transdermal Skin Patch Revenue by Region (2018-2023)
6.2 APAC Medical Nicotine Transdermal Skin Patch Sales by Type
6.3 APAC Medical Nicotine Transdermal Skin Patch Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Medical Nicotine Transdermal Skin Patch by Country
7.1.1 Europe Medical Nicotine Transdermal Skin Patch Sales by Country (2018-2023)
7.1.2 Europe Medical Nicotine Transdermal Skin Patch Revenue by Country (2018-2023)
7.2 Europe Medical Nicotine Transdermal Skin Patch Sales by Type
7.3 Europe Medical Nicotine Transdermal Skin Patch Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Medical Nicotine Transdermal Skin Patch by Country
8.1.1 Middle East & Africa Medical Nicotine Transdermal Skin Patch Sales by Country (2018-2023)
8.1.2 Middle East & Africa Medical Nicotine Transdermal Skin Patch Revenue by Country (2018-2023)
8.2 Middle East & Africa Medical Nicotine Transdermal Skin Patch Sales by Type
8.3 Middle East & Africa Medical Nicotine Transdermal Skin Patch Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Medical Nicotine Transdermal Skin Patch
10.3 Manufacturing Process Analysis of Medical Nicotine Transdermal Skin Patch
10.4 Industry Chain Structure of Medical Nicotine Transdermal Skin Patch
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Medical Nicotine Transdermal Skin Patch Distributors
11.3 Medical Nicotine Transdermal Skin Patch Customer
12 World Forecast Review for Medical Nicotine Transdermal Skin Patch by Geographic Region
12.1 Global Medical Nicotine Transdermal Skin Patch Market Size Forecast by Region
12.1.1 Global Medical Nicotine Transdermal Skin Patch Forecast by Region (2024-2029)
12.1.2 Global Medical Nicotine Transdermal Skin Patch Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Medical Nicotine Transdermal Skin Patch Forecast by Type
12.7 Global Medical Nicotine Transdermal Skin Patch Forecast by Application
13 Key Players Analysis
13.1 Habitrol
13.1.1 Habitrol Company Information
13.1.2 Habitrol Medical Nicotine Transdermal Skin Patch Product Portfolios and Specifications
13.1.3 Habitrol Medical Nicotine Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Habitrol Main Business Overview
13.1.5 Habitrol Latest Developments
13.2 Nicotrol
13.2.1 Nicotrol Company Information
13.2.2 Nicotrol Medical Nicotine Transdermal Skin Patch Product Portfolios and Specifications
13.2.3 Nicotrol Medical Nicotine Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Nicotrol Main Business Overview
13.2.5 Nicotrol Latest Developments
13.3 Nicoderm
13.3.1 Nicoderm Company Information
13.3.2 Nicoderm Medical Nicotine Transdermal Skin Patch Product Portfolios and Specifications
13.3.3 Nicoderm Medical Nicotine Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Nicoderm Main Business Overview
13.3.5 Nicoderm Latest Developments
13.4 Aroamas Cot
13.4.1 Aroamas Cot Company Information
13.4.2 Aroamas Cot Medical Nicotine Transdermal Skin Patch Product Portfolios and Specifications
13.4.3 Aroamas Cot Medical Nicotine Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Aroamas Cot Main Business Overview
13.4.5 Aroamas Cot Latest Developments
13.5 Hisamitsu Pharmaceutica
13.5.1 Hisamitsu Pharmaceutica Company Information
13.5.2 Hisamitsu Pharmaceutica Medical Nicotine Transdermal Skin Patch Product Portfolios and Specifications
13.5.3 Hisamitsu Pharmaceutica Medical Nicotine Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Hisamitsu Pharmaceutica Main Business Overview
13.5.5 Hisamitsu Pharmaceutica Latest Developments
13.6 Novartis
13.6.1 Novartis Company Information
13.6.2 Novartis Medical Nicotine Transdermal Skin Patch Product Portfolios and Specifications
13.6.3 Novartis Medical Nicotine Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Novartis Main Business Overview
13.6.5 Novartis Latest Developments
13.7 Johnson & Johnson
13.7.1 Johnson & Johnson Company Information
13.7.2 Johnson & Johnson Medical Nicotine Transdermal Skin Patch Product Portfolios and Specifications
13.7.3 Johnson & Johnson Medical Nicotine Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Johnson & Johnson Main Business Overview
13.7.5 Johnson & Johnson Latest Developments
13.8 Teikoku Pharma
13.8.1 Teikoku Pharma Company Information
13.8.2 Teikoku Pharma Medical Nicotine Transdermal Skin Patch Product Portfolios and Specifications
13.8.3 Teikoku Pharma Medical Nicotine Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Teikoku Pharma Main Business Overview
13.8.5 Teikoku Pharma Latest Developments
13.9 Mylan
13.9.1 Mylan Company Information
13.9.2 Mylan Medical Nicotine Transdermal Skin Patch Product Portfolios and Specifications
13.9.3 Mylan Medical Nicotine Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Mylan Main Business Overview
13.9.5 Mylan Latest Developments
13.10 Actavis
13.10.1 Actavis Company Information
13.10.2 Actavis Medical Nicotine Transdermal Skin Patch Product Portfolios and Specifications
13.10.3 Actavis Medical Nicotine Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Actavis Main Business Overview
13.10.5 Actavis Latest Developments
13.11 Mundipharma
13.11.1 Mundipharma Company Information
13.11.2 Mundipharma Medical Nicotine Transdermal Skin Patch Product Portfolios and Specifications
13.11.3 Mundipharma Medical Nicotine Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Mundipharma Main Business Overview
13.11.5 Mundipharma Latest Developments
13.12 Henan Lingrui pharmaceutical
13.12.1 Henan Lingrui pharmaceutical Company Information
13.12.2 Henan Lingrui pharmaceutical Medical Nicotine Transdermal Skin Patch Product Portfolios and Specifications
13.12.3 Henan Lingrui pharmaceutical Medical Nicotine Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Henan Lingrui pharmaceutical Main Business Overview
13.12.5 Henan Lingrui pharmaceutical Latest Developments
13.13 Changzhou Siyao
13.13.1 Changzhou Siyao Company Information
13.13.2 Changzhou Siyao Medical Nicotine Transdermal Skin Patch Product Portfolios and Specifications
13.13.3 Changzhou Siyao Medical Nicotine Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Changzhou Siyao Main Business Overview
13.13.5 Changzhou Siyao Latest Developments
13.14 Rfl Pharmaceutical
13.14.1 Rfl Pharmaceutical Company Information
13.14.2 Rfl Pharmaceutical Medical Nicotine Transdermal Skin Patch Product Portfolios and Specifications
13.14.3 Rfl Pharmaceutical Medical Nicotine Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Rfl Pharmaceutical Main Business Overview
13.14.5 Rfl Pharmaceutical Latest Developments
13.15 Luye Pharma Group Ltd.
13.15.1 Luye Pharma Group Ltd. Company Information
13.15.2 Luye Pharma Group Ltd. Medical Nicotine Transdermal Skin Patch Product Portfolios and Specifications
13.15.3 Luye Pharma Group Ltd. Medical Nicotine Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Luye Pharma Group Ltd. Main Business Overview
13.15.5 Luye Pharma Group Ltd. Latest Developments
13.16 Purdue Pharma L.P
13.16.1 Purdue Pharma L.P Company Information
13.16.2 Purdue Pharma L.P Medical Nicotine Transdermal Skin Patch Product Portfolios and Specifications
13.16.3 Purdue Pharma L.P Medical Nicotine Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Purdue Pharma L.P Main Business Overview
13.16.5 Purdue Pharma L.P Latest Developments
13.17 Teva Pharmaceutical Industries
13.17.1 Teva Pharmaceutical Industries Company Information
13.17.2 Teva Pharmaceutical Industries Medical Nicotine Transdermal Skin Patch Product Portfolios and Specifications
13.17.3 Teva Pharmaceutical Industries Medical Nicotine Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Teva Pharmaceutical Industries Main Business Overview
13.17.5 Teva Pharmaceutical Industries Latest Developments
14 Research Findings and Conclusion